Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science
- PMID: 37454344
- DOI: 10.1002/btpr.3374
Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science
Abstract
Mesenchymal Stem Cells (MSCs) are non-hematopoietic and multipotent stem cells, which have been considered in regenerative medicine. These cells are easily separated from different sources, such as bone marrow (BM), umbilical cord (UC), adipose tissue (AT), and etc. MSCs have the differentiation capability into chondrocytes, osteocytes, and adipocytes; This differentiation potential along with the paracrine properties have made them a key choice for tissue repair. MSCs also have various advantages over other stem cells, which is why they have been extensively studied in recent years. The effectiveness of MSCs-based therapies depend on several factors, including differentiation status at the time of use, concentration per injection, delivery method, the used vehicle, and the nature and extent of the damage. Although, MSCs have emerged promising sources for regenerative medicine, there are potential risks regarding their safety in their clinical use, including tumorigenesis, lack of availability, aging, and sensitivity to toxic environments. In this study, we aimed to discuss how MSCs may be useful in treating defects and diseases. To this aim, we will review recent advances of MSCs action mechanisms in regenerative medicine, as well as the most recent clinical trials. We will also have a brief overview of MSCs resources, differences between their sources, culture conditions, extraction methods, and clinical application of MSCs in various fields of regenerative medicine.
Keywords: cell therapy; mesenchymal stem cell; regenerative medicine; self-renewal; tissue repair.
© 2023 American Institute of Chemical Engineers.
References
REFERENCES
-
- Al-Khawaga S, Abdelalim EM. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients. Stem Cell Res Ther. 2020;11(1):437. doi:10.1186/s13287-020-01963-6
-
- Xiao K, Hou F, Huang X, Li B, Qian ZR, Xie L. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19. Stem Cell Res Ther. 2020;11(1):305. doi:10.1186/s13287-020-01804-6
-
- Tozetti PA, Caruso SR, Mizukami A, et al. Expansion strategies for human mesenchymal stromal cells culture under xeno-free conditions. Biotechnol Prog. 2017;33(5):1358-1367. doi:10.1002/btpr.2494
-
- Gugliandolo A, Bramanti P, Mazzon E. Mesenchymal stem cells in multiple sclerosis: recent evidence from pre-clinical to clinical studies. Int J Mol Sci. 2020;21(22):8662. doi:10.3390/ijms21228662
-
- Gupta A, Kashte S, Gupta M, Rodriguez HC, Gautam SS, Kadam S. Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective. Hum Cell. 2020;33(4):907-918. doi:10.1007/s13577-020-00407-w
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources